Cancer therapies often aim to disrupt the replication process in cancer cells. Chemotherapy drugs, for instance, target rapidly dividing cells, causing DNA damage that triggers cell death. Radiation therapy similarly induces DNA damage in cancer cells. More targeted approaches, such as PARP inhibitors, specifically interfere with DNA repair mechanisms in cancer cells, making them more susceptible to damage.
